Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index; 7 of the 9 sources its claims cite were checked for support.

Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder

Open access

Abstract

Introduction Opioid therapy is often central to pain management during cancer care. However, opioid exposure and unaddressed psychological suffering jointly amplify opioid use disorder risk. Therefore, we iteratively developed a behavioural, individually delivered intervention to mitigate the risk of opioid use disorder during cancer care (Acceptance and Commitment Therapy Intervention when Opioids are Necessary (ACTION)). Methods and analysis This is a single-site, non-blinded, randomised, controlled pilot trial of ACTION compared with a waitlist control group. The aims of this study are to examine the feasibility (defined as an overall enrolment rate of ≥60% and a retention rate of >75%) and acceptability (assessed via patient-reported feedback in exit interviews and Client Satisfaction Questionnaire-8 ratings) of ACTION (primary outcomes) and to assess changes in participant-reported depression, anxiety and opioid misuse (secondary outcomes). Patients will be recruited from Dana-Farber Cancer Institute (Boston, Massachusetts, USA). The total number of patients completing the study will be 40. All patients will complete baseline and follow-up measures after 6 weeks. Patients randomly assigned to ACTION (n=20) will receive six weekly 30-min sessions delivered by a mental health provider either via telehealth or in-person. Patients assigned to the waitlist control group (n=20) will be offered the intervention on completion of their follow-up assessments, approximately 6 weeks (±2 weeks), following baseline. Ethics and dissemination This study is approved by the Dana-Farber/Harvard Cancer Center Institutional Review Board (Protocol #21-587). Participants provide either written or electronic informed consent on study approach and once enrolled, they can withdraw from the study at any time. Results will be published in peer-reviewed journals and presented at scientific meetings. Trial registration number NCT05643027. © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.

Overview

CoChat Summary

TL;DR

This paper is a protocol for a single-site, non-blinded pilot randomized controlled trial of ACTION, a virtual behavioral intervention for adults with cancer at risk for opioid use disorder. The trial will compare ACTION with a waitlist control in 40 patients, with the main goals of testing feasibility and acceptability and collecting preliminary changes in depression, anxiety, and opioid misuse.

Key findings

  • The study’s primary feasibility targets are an overall enrolment rate of ≥60% and a retention rate of >75%; acceptability will be assessed with exit interviews and Client Satisfaction Questionnaire-8 (CSQ-8) ratings.
  • The planned sample is 40 patients, randomized 1:1 to ACTION (n=20) or waitlist control (n=20); as of 21 October 2024, 5 participants had enrolled (2 treatment, 3 control).
  • The intervention consists of six weekly 30-minute sessions, delivered by a mental health provider via telehealth or in person, plus a workbook; follow-up assessments occur at 6 weeks (±2 weeks).
  • The authors report this is the first manualised behavioural intervention targeting opioid use disorder risk during cancer care, and that it uses Acceptance and Commitment Therapy to address depression, anxiety, coping, and related risk factors.

Methods

  • Single-site, non-blinded, randomized, controlled pilot feasibility trial at Dana-Farber Cancer Institute in Boston.
  • Eligible participants are adults ≥18 years with any cancer diagnosis, on opioid therapy, at risk for opioid use disorder (Opioid Risk Tool score ≥4), English-speaking enough for psychotherapy, and with estimated survival ≥6 months; patients with cognitive impairment, untreated psychosis, bipolar disorder, or borderline personality disorder are excluded.
  • Primary analysis is descriptive/feasibility-focused: enrolment and retention, acceptability (CSQ-8 and interviews), and estimation of effect sizes for secondary outcomes (depression PHQ-9, anxiety GAD-7, opioid misuse COMM), with pilot-oriented analyses rather than inferential hypothesis testing.

Limitations

  • The paper states the study is limited to patients receiving care at a Boston-area academic cancer centre, which limits generalisability.
  • The paper states that requiring access to videoconferencing-capable devices may bias the sample toward individuals with higher incomes and education.
  • The paper states the trial is not blinded and is underpowered for secondary outcomes; additionally, it notes survey noncompletion may indicate that the assessment battery is too long for a future full-scale trial.
  • Evident from the protocol: results are not yet available because this is a study protocol for an ongoing trial, not a completed outcome study.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2024-096546

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 CONSORT flow diagram. CONSORT, Consolidated Standards of Reporting Trials; ORT, Opioid Risk Tool.
Figure 1 CONSORT flow diagram. CONSORT, Consolidated Standards of Reporting Trials; ORT, Opioid Risk Tool.CC BY-NC · PubMed Central

Verification

Claims the paper makes

7 Valid · 0 Not valid · 1 Not checked · 13 Own results and interpretations

7 more claims · 2 with their cited sources checked

Create a free account to see all 21 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 5
  • It may state two separate claims as one. 5

Create a free account to see these claims.

Citations

Cites

Show all 31 references

Cited by

See all 1

Metadata

Authors
Yusufov, M., Pirl, W. F., Greer, J. A., Mazzola, E., Dalrymple, K. L., Tulsky, J. A., Braun, I. M., & McHugh, R. K.
Affiliations
  • Harvard University (US)
  • Brown University (US)
Corresponding author
Yusufov, Miryam
Venue
BMJ Open
Publisher
BMJ
Published
2024-12
Volume
14
Issue
12
Pages
e096546
ISSN
2044-6055 (ISSN-L)
OpenAlex
W4405128019
Cited by
1
References
31
Citations by year
2026: 1
FWCI
0.41
Type
journal article
Language
en
Open access
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
Funders
National Cancer Institute (K08 CA 259538; PI: Yusufov)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
opioid use disorder, cancer pain management, acceptance and commitment therapy, behavioral interventions, depression, anxiety, opioid misuse, feasibility and acceptability
MeSH terms
Cancer Pain, Adult, Analgesics, Opioid, Behavior Therapy, Feasibility Studies, Female, Humans, Male, Opioid-Related Disorders, Neoplasms, Pilot Projects, Randomized Controlled Trials as Topic, Pain Management, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder. https://app.cochat.ai/papers/10.1136/bmjopen-2024-096546
The paper
Yusufov, M., Pirl, W. F., Greer, J. A., Mazzola, E., Dalrymple, K. L., Tulsky, J. A., Braun, I. M., & McHugh, R. K. (2024). Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder. BMJ Open. https://doi.org/10.1136/bmjopen-2024-096546

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.